Cargando…

P1196: ORIENT STUDY: REGIMEN OF ORELABRUTINIB PLUS R-CHOP-LIKE FOR PATIENTS WITH NEWLY DIAGNOSED UNTREATED NON-GCB DLBCL

Detalles Bibliográficos
Autores principales: Qu, Chang-Ju, Liu, Hai-Ling, Zou, Rui, Ping, Na-Na, Zhu, Qian, Zhang, Xiao, He, Jia-Jie, Wu, De-Pei, Jin, Zheng-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430923/
http://dx.doi.org/10.1097/01.HS9.0000971680.91846.5b
_version_ 1785091076064804864
author Qu, Chang-Ju
Liu, Hai-Ling
Zou, Rui
Ping, Na-Na
Zhu, Qian
Zhang, Xiao
He, Jia-Jie
Wu, De-Pei
Jin, Zheng-Ming
author_facet Qu, Chang-Ju
Liu, Hai-Ling
Zou, Rui
Ping, Na-Na
Zhu, Qian
Zhang, Xiao
He, Jia-Jie
Wu, De-Pei
Jin, Zheng-Ming
author_sort Qu, Chang-Ju
collection PubMed
description
format Online
Article
Text
id pubmed-10430923
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104309232023-08-17 P1196: ORIENT STUDY: REGIMEN OF ORELABRUTINIB PLUS R-CHOP-LIKE FOR PATIENTS WITH NEWLY DIAGNOSED UNTREATED NON-GCB DLBCL Qu, Chang-Ju Liu, Hai-Ling Zou, Rui Ping, Na-Na Zhu, Qian Zhang, Xiao He, Jia-Jie Wu, De-Pei Jin, Zheng-Ming Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430923/ http://dx.doi.org/10.1097/01.HS9.0000971680.91846.5b Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Qu, Chang-Ju
Liu, Hai-Ling
Zou, Rui
Ping, Na-Na
Zhu, Qian
Zhang, Xiao
He, Jia-Jie
Wu, De-Pei
Jin, Zheng-Ming
P1196: ORIENT STUDY: REGIMEN OF ORELABRUTINIB PLUS R-CHOP-LIKE FOR PATIENTS WITH NEWLY DIAGNOSED UNTREATED NON-GCB DLBCL
title P1196: ORIENT STUDY: REGIMEN OF ORELABRUTINIB PLUS R-CHOP-LIKE FOR PATIENTS WITH NEWLY DIAGNOSED UNTREATED NON-GCB DLBCL
title_full P1196: ORIENT STUDY: REGIMEN OF ORELABRUTINIB PLUS R-CHOP-LIKE FOR PATIENTS WITH NEWLY DIAGNOSED UNTREATED NON-GCB DLBCL
title_fullStr P1196: ORIENT STUDY: REGIMEN OF ORELABRUTINIB PLUS R-CHOP-LIKE FOR PATIENTS WITH NEWLY DIAGNOSED UNTREATED NON-GCB DLBCL
title_full_unstemmed P1196: ORIENT STUDY: REGIMEN OF ORELABRUTINIB PLUS R-CHOP-LIKE FOR PATIENTS WITH NEWLY DIAGNOSED UNTREATED NON-GCB DLBCL
title_short P1196: ORIENT STUDY: REGIMEN OF ORELABRUTINIB PLUS R-CHOP-LIKE FOR PATIENTS WITH NEWLY DIAGNOSED UNTREATED NON-GCB DLBCL
title_sort p1196: orient study: regimen of orelabrutinib plus r-chop-like for patients with newly diagnosed untreated non-gcb dlbcl
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430923/
http://dx.doi.org/10.1097/01.HS9.0000971680.91846.5b
work_keys_str_mv AT quchangju p1196orientstudyregimenoforelabrutinibplusrchoplikeforpatientswithnewlydiagnoseduntreatednongcbdlbcl
AT liuhailing p1196orientstudyregimenoforelabrutinibplusrchoplikeforpatientswithnewlydiagnoseduntreatednongcbdlbcl
AT zourui p1196orientstudyregimenoforelabrutinibplusrchoplikeforpatientswithnewlydiagnoseduntreatednongcbdlbcl
AT pingnana p1196orientstudyregimenoforelabrutinibplusrchoplikeforpatientswithnewlydiagnoseduntreatednongcbdlbcl
AT zhuqian p1196orientstudyregimenoforelabrutinibplusrchoplikeforpatientswithnewlydiagnoseduntreatednongcbdlbcl
AT zhangxiao p1196orientstudyregimenoforelabrutinibplusrchoplikeforpatientswithnewlydiagnoseduntreatednongcbdlbcl
AT hejiajie p1196orientstudyregimenoforelabrutinibplusrchoplikeforpatientswithnewlydiagnoseduntreatednongcbdlbcl
AT wudepei p1196orientstudyregimenoforelabrutinibplusrchoplikeforpatientswithnewlydiagnoseduntreatednongcbdlbcl
AT jinzhengming p1196orientstudyregimenoforelabrutinibplusrchoplikeforpatientswithnewlydiagnoseduntreatednongcbdlbcl